
"Human Trials Begin for Groundbreaking Nipah Virus Vaccine"
The University of Oxford has initiated the first human trial for a vaccine against the Nipah virus, a zoonotic pathogen with a mortality rate of up to 75%. The ChAdOx1 NipahB vaccine is being tested on 51 volunteers to evaluate its safety and immune responses. With no approved vaccines or treatments for Nipah virus, this trial marks a significant step in pandemic preparedness, and further research is expected to follow in Nipah virus-affected countries.












